1,2-Benzoxazol-3-yl(spiro[1,2-dihydroindene-3,4'-piperidine]-1'-yl)methanone

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并异恶唑
• 英文名称: 1,2-Benzoxazol-3-yl(spiro[1,2-dihydroindene-3,4'-piperidine]-1'-yl)methanone
• 英文别名: 1,2-benzoxazol-3-yl(spiro[1,2-dihydroindene-3,4'-piperidine]-1'-yl)methanone
• 化学式: C₂₁H₂₀N₂O₂
• 分子量: 332.4
• InChiKey: OJMIYKHBNLRKOA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  25
• 可旋转键数：
  1
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  46.3
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• [EN] MODULATORS OF VASOPRESSIN RECEPTORS WITH THERAPEUTIC POTENTIAL<br/>[FR] MODULATEURS DES RÉCEPTEURS DE LA VASOPRESSINE À POUVOIR THÉRAPEUTIQUE
  申请人：SCRIPPS RESEARCH INST

  公开号：WO2014127350A1

  公开（公告）日：2014-08-21

  Compounds comprising piperazines, piperidines, spiro-furanopiperidines, and analogs thereof are provided that are modulators, such as positive allosteric modulators, of one or more subclasses of vasopressin receptors. The compounds can be selective modulators of one or more subclasses of vasopressin receptors. Compounds of the invention can be used in the treatment of a condition wherein modulating a vasopressin receptor is medically indicated for treatment of the condition.

  提供了包含哌嗪、哌啶、螺环呋喃哌啶及其类似物的化合物，这些化合物是利钠素受体的调节剂，如正向变构调节剂，可以调节一个或多个亚类别的利钠素受体。这些化合物可以是一个或多个亚类别的利钠素受体的选择性调节剂。本发明的化合物可用于治疗需要调节利钠素受体的情况。
• MODULATORS OF VASOPRESSIN RECEPTORS WITH THERAPEUTIC POTENTIAL
  申请人：THE SCRIPPS RESEARCH INSTITUTE

  公开号：US20150376198A1

  公开（公告）日：2015-12-31

  Compounds comprising piperazines, piperidines, spiro-furanopiperidines, and analogs thereof are provided that are modulators, such as positive allosteric modulators, of one or more subclasses of vasopressin receptors. The compounds can be selective modulators of one or more subclasses of vasopressin receptors. Compounds of the invention can be used in the treatment of a condition wherein modulating a vasopressin receptor is medically indicated for treatment of the condition.